Trial
NCT05167526
A Study to Find a Suitable Dose of ASP8731 and Check for Medical Problems at Each Dose in Healthy Adults
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Astellas Pharma Global Development, Inc.
Collaborators
—
Condition
Healthy Participants
Intervention
ASP8731
Why stopped
The study was terminated due to protocol defined stopping criteria being met.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-20